Chaperone-Enabled studies of epigenetic regulation enzymes
表观遗传调控酶的伴侣蛋白研究
基本信息
- 批准号:8730671
- 负责人:
- 金额:$ 132.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAnimal ModelBindingBiologicalBiological AssayBiological ProcessBiologyCatalogingCatalogsCatalysisCell NucleusCellsChicagoCommunitiesComplexContractsCrystallizationDNA RepairDNA biosynthesisDiseaseElementsEnsureEnvironmentEnzymesEpigenetic ProcessFamilyGene ExpressionGene SilencingGenerationsGenetic RecombinationGoalsHistonesHumanIn VitroIndividualKnowledgeLaboratoriesLeadLifeLysineManagement Information SystemsMediatingMediator of activation proteinMethylationModificationMolecularMolecular ChaperonesMolecular ConformationMorphologic artifactsMultiprotein ComplexesMutationOrganismPerformancePhage DisplayPost-Translational Protein ProcessingPrincipal InvestigatorProbabilityProductionPropertyProtein EngineeringProtein Structure InitiativeProteinsRNA ProcessingReagentRegulationResearchResearch InfrastructureResearch PersonnelResourcesSet proteinSignal TransductionSiteSpecificityStructureStructure-Activity RelationshipSurfaceSystemTechnologyTimeUnited States National Institutes of HealthUniversitiesbasecell typecellular imagingdesigndrug developmentenzyme activityenzyme substrate complexflexibilitygene repressionhistone methyltransferasehistone modificationimprintin vivoinhibitor/antagonistmeetingsmemberoperationparalogous geneprogramsprotein complexprotein protein interactionpublic health relevancereceptorrecombinational repairresearch studysuccess
项目摘要
DESCRIPTION (provided by applicant): The overarching goal of this project is to elucidate the molecular mechanism governing the catalysis and regulation of histone modification enzymes. We will use our Chaperone-Enabled Biology and Structure (CEBS) technology platform to study an important, but challenging group of epigenetic regulating enzymes. The lysine-specific histone methyltransferases (HMT) and their complementary partners, lysine demethylases (KDM) function as key mediators of epigenetic signaling through their actions as "writers and erasers" of post-translational modifications on histone proteins. Numerous recent studies have highlighted the importance of lysine methylation of histones leading to direct impact on DNA replication, repair, recombination, gene silencing, imprinting and RNA processes making these enzymes potential key targets for drug development. However, progress in gaining fundamental knowledge about structure-function relationships governing their modes of operation has been slow because they are multidomain proteins and have been recalcitrant to both structural and functional analyses. To overcome the existing barriers, we will generate specialized reagents called "synthetic affinity binders" or sABs that will be used as chaperones for
crystallization, as well as customized affinity reagents for cell biologically applications. To accomplish our objectives we have assembled a world-class team of investigators that will exploit sAB reagents for both structure determination and high level biological assays. A major emphasis of our approach is to identify and structurally/biochemically characterize the molecular complexes in which the HMTs and KDMs function by using sABs that stabilize and enhance crystallization of the complexes. Thus, CEBS effort will rely on close ties to the large high throughput centers for protein production and structure determination of individual enzymes in multiple conformational states, enzyme-substrate complexes and multiprotein complexes. A unique strength of our approach is that we will provide crystallization chaperones and the information on interaction partners to the high throughput centers to greatly increase the probability of success of structure determination.
描述(由申请人提供):该项目的总体目标是阐明组蛋白修饰酶催化和调节的分子机制。我们将使用我们的伴侣分子生物学和结构(CEBS)技术平台来研究一组重要但具有挑战性的表观遗传调节酶。赖氨酸特异性组蛋白甲基转移酶 (HMT) 及其互补伙伴赖氨酸脱甲基酶 (KDM) 通过对组蛋白翻译后修饰发挥“书写者和擦除者”作用,充当表观遗传信号转导的关键介质。最近的许多研究强调了组蛋白赖氨酸甲基化的重要性,它对 DNA 复制、修复、重组、基因沉默、印记和 RNA 过程产生直接影响,使这些酶成为药物开发的潜在关键靶标。然而,在获得有关控制其操作模式的结构-功能关系的基础知识方面进展缓慢,因为它们是多域蛋白质并且难以进行结构和功能分析。为了克服现有的障碍,我们将生产称为“合成亲和力结合剂”或 sAB 的专用试剂,将其用作分子伴侣
结晶,以及用于细胞生物学应用的定制亲和试剂。为了实现我们的目标,我们组建了一支世界一流的研究团队,将利用 sAB 试剂进行结构测定和高水平生物测定。我们方法的一个主要重点是通过使用稳定和增强复合物结晶的 sAB 来识别和结构/生物化学表征 HMT 和 KDM 在其中发挥作用的分子复合物。因此,CEBS 的工作将依赖于与大型高通量中心的密切联系,用于蛋白质生产和多种构象状态下的单个酶、酶-底物复合物和多蛋白复合物的结构测定。我们方法的独特优势在于,我们将向高通量中心提供结晶伴侣和相互作用伙伴的信息,以大大提高结构测定的成功概率。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
- DOI:10.1016/j.jmb.2012.11.037
- 发表时间:2013-02-22
- 期刊:
- 影响因子:5.6
- 作者:Persson, Helena;Ye, Wei;Wernimont, Amy;Adams, Jarrett J.;Koide, Akiko;Koide, Shohei;Lam, Robert;Sidhu, Sachdev S.
- 通讯作者:Sidhu, Sachdev S.
A New Versatile Immobilization Tag Based on the Ultra High Affinity and Reversibility of the Calmodulin-Calmodulin Binding Peptide Interaction.
- DOI:10.1016/j.jmb.2015.06.018
- 发表时间:2015-08-14
- 期刊:
- 影响因子:5.6
- 作者:Mukherjee S;Ura M;Hoey RJ;Kossiakoff AA
- 通讯作者:Kossiakoff AA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTHONY A KOSSIAKOFF其他文献
ANTHONY A KOSSIAKOFF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTHONY A KOSSIAKOFF', 18)}}的其他基金
Chaperone-Assisted Structure Determination of Membrane Proteins
分子伴侣辅助膜蛋白结构测定
- 批准号:
10549305 - 财政年份:2016
- 资助金额:
$ 132.14万 - 项目类别:
Chaperone-Assisted Structure Determination of Membrane Proteins
分子伴侣辅助膜蛋白结构测定
- 批准号:
10321297 - 财政年份:2016
- 资助金额:
$ 132.14万 - 项目类别:
Chaperone-Assisted Structure Determination of Membrane Proteins
分子伴侣辅助膜蛋白结构测定
- 批准号:
9887438 - 财政年份:2016
- 资助金额:
$ 132.14万 - 项目类别:
Chaperone-Assisted Structure Determination of Membrane Proteins
分子伴侣辅助膜蛋白结构测定
- 批准号:
9007806 - 财政年份:2016
- 资助金额:
$ 132.14万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 132.14万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 132.14万 - 项目类别:
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
- 批准号:
10726508 - 财政年份:2023
- 资助金额:
$ 132.14万 - 项目类别: